Literature DB >> 7747202

Does affordability affect mental health utilization? A United States-Israel comparison of older adults.

M C Feinson1, M Popper.   

Abstract

The affordability of treatment is considered a major influence on the utilization of mental health services, a premise empirically examined in this research. Utilization patterns in the U.S. are compared with Israel, a country where access to treatment is not influenced by costs and their coverage. The focus is primarily on older adults, whose consistently low use of ambulatory services (in U.S.) has been attributed to financial barriers. The finding challenge the affordability-utilization assumption: (1) older Israeli ambulatory use is lower than in the U.S.; (2) Israel elders have the lowest rates of all adult groups, the same pattern as in the U.S.; (3) older Israelis have a substantially higher inpatient rate than younger Israelis (< 65), a pattern dissimilar from the U.S. These findings have important implications for policymakers who attempt to address underserved groups by reducing financial barriers. Israeli data provide compelling evidence that affordability may be less relevant to mental health than to other health services. A more promising research focus is on those organizational, professional and other structural factors which shape the system and influence how, where, and to whom treatment is provided.

Mesh:

Year:  1995        PMID: 7747202     DOI: 10.1016/0277-9536(94)e0108-5

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  2 in total

1.  The effects of health sector market factors and vulnerable group membership on access to alcohol, drug, and mental health care.

Authors:  Susan E Stockdale; Lingqi Tang; Lily Zhang; Thomas R Belin; Kenneth B Wells
Journal:  Health Serv Res       Date:  2007-06       Impact factor: 3.402

2.  Trends in Medicare Part B mental health utilization and expenditures: 1987-92.

Authors:  M L Rosenbach; C J Ammering
Journal:  Health Care Financ Rev       Date:  1997
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.